Reconfigurable Amphiphilic DNA Nanotweezer for Targeted Delivery of Therapeutic Oligonucleotides
2024

DNA Nanotweezer for Targeted Delivery of Oligonucleotides

publication 10 minutes Evidence: high

Author Information

Author(s): Shao Shuxuan, Du Wei, Liu Shuang, Hu Canqiong, Zhang Cao, Li Lexun, Yang Fan, Liu Qiaoling, Tan Weihong

Primary Institution: Hunan University

Hypothesis

Can a reconfigurable DNA nanotweezer improve the targeted delivery of therapeutic oligonucleotides?

Conclusion

The reconfigurable DNA nanotweezer effectively enhances the targeted delivery of therapeutic oligonucleotides and inhibits tumor growth.

Supporting Evidence

  • The DNA nanotweezer showed enhanced accumulation at tumor sites.
  • It effectively inhibited tumor growth in A549 cells.
  • The study demonstrated a significant reduction in c-Met and c-raf protein levels.
  • NT-Ch2-Apt showed negligible cytotoxicity to non-target HeLa cells.
  • The reconfigurable design allows for selective membrane anchoring.
  • Fluorescence imaging confirmed the targeted delivery capability.
  • Cell viability assays indicated a dose-dependent killing effect on cancer cells.
  • Western blot analysis showed downregulation of key proteins involved in cancer progression.

Takeaway

Scientists created a special DNA tool that can deliver medicine directly to cancer cells, helping to stop tumors from growing.

Methodology

The study involved designing a DNA nanotweezer that changes shape to improve its ability to attach to cancer cells and deliver therapeutic oligonucleotides.

Limitations

The study primarily focused on in vitro and in vivo models, which may not fully represent human responses.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1021/acscentsci.4c01152

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication